Integration and interplay of machine learning and bioinformatics approach to identify genetic interaction related to ovarian cancer chemoresistance.

Journal: Briefings in bioinformatics
Published Date:

Abstract

Although chemotherapy is the first-line treatment for ovarian cancer (OCa) patients, chemoresistance (CR) decreases their progression-free survival. This paper investigates the genetic interaction (GI) related to OCa-CR. To decrease the complexity of establishing gene networks, individual signature genes related to OCa-CR are identified using a gradient boosting decision tree algorithm. Additionally, the genetic interaction coefficient (GIC) is proposed to measure the correlation of two signature genes quantitatively and explain their joint influence on OCa-CR. Gene pair that possesses high GIC is identified as signature pair. A total of 24 signature gene pairs are selected that include 10 individual signature genes and the influence of signature gene pairs on OCa-CR is explored. Finally, a signature gene pair-based prediction of OCa-CR is identified. The area under curve (AUC) is a widely used performance measure for machine learning prediction. The AUC of signature gene pair reaches 0.9658, whereas the AUC of individual signature gene-based prediction is 0.6823 only. The identified signature gene pairs not only build an efficient GI network of OCa-CR but also provide an interesting way for OCa-CR prediction. This improvement shows that our proposed method is a useful tool to investigate GI related to OCa-CR.

Authors

  • Kexin Chen
    Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou, China.
  • Haoming Xu
    Department of Biomedical Engineering, Duke University, 27708, Durham, United States.
  • Yiming Lei
    Shanghai Key Laboratory of Intelligent Information Processing, School of Computer Science, Fudan University, Shanghai 200433, China.
  • Pietro Lió
    Computer Laboratory, University of Cambridge, 15 JJ Thomson Avenue, Cambridge, UK.
  • Yuan Li
    NHC Key Lab of Hormones and Development and Tianjin Key Lab of Metabolic Diseases, Tianjin Medical University Chu Hsien-I Memorial Hospital & Institute of Endocrinology, Tianjin, China.
  • Hongyan Guo
    Department of Obstetrics and Gynecology, Peking University Third Hospital, 100083, Beijing, China.
  • Mohammad Ali Moni
    School of Public health and Community Medicine, University of New South Wales, 2052, Sydney, Australia.